Trial intelligence / Profile preview

VOCAL: Voclosporin in Adolescents with Lupus Nephritis

jRCT2051250008Phase 2Suspended

Sponsor
Aurinia
Start
Apr 2025
Modality
Small Molecules
01

Overview

Phase 2, randomised, double-blind trial of voclosporin in lupus nephritis (LN) (4 arms), sponsored by Aurinia. Primary endpoint: Renal response at Week 24. Started Apr 2025; status: suspended.

02

Drugs

voclosporin
03

Conditions

lupus nephritis (LN)

Beyond the preview

Go deeper on jRCT2051250008.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCT2051250008.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call